| ACET |    | Adicet Bio, Inc. - Common Stock | | | 1.88% up -10.19% 12.07 | | + Medicine, Cancer fight
| + My List |
| ADAP | | Adaptimmune Therapeutics plc - American Depositary Shares | | | 7.56% 7.56% 0 | | + Medicine, Cancer fight
Last highlighted: #ADAP SEC report: Adaptimmune Therapeutics PLC Statement of changes in beneficial ownership of securities | + My List |
| AEMD | | Aethlon Medical, Inc. - Common Stock | | | -11.8% -11.8% 0 | | + Health Devices, Medicine, Cancer fight
| + My List |
| AFMD | | Affimed N.V. - Common Stock | | | 8.59% 8.59% 0 | | + Immunology, Cancer fight, Medicine
| + My List |
| AGEN | | Agenus Inc. - Common Stock | | | up -7.45% 7.45 | | + Cancer fight, Immunology, Medicine
Last highlighted: #AGEN SEC report: AGENUS INC Statement of changes in beneficial ownership of securities | + My List |
| AIKI | | AIkido Pharma Inc. - Common Stock | | | -1.6% down 7.21% -8.81 | | + Cancer fight, Pharmaceutical , Medicine
Last highlighted: #AIKI SEC report: AIkido Pharma Inc. Current report, item 8.01
SEC Filing Form 8-K filed by AIkido Pharma Inc. -- SEC File Number 211098058 | + My List |
| AKER | | Akers Biosciences Inc. - Common Stock | | | 0.00% 0 | | + Medicine, Pharmaceutical , Immunology, Cancer fight
| + My List |
| ALLO | | Allogene Therapeutics, Inc. - Common Stock | | | up -7.15% 7.15 | | + Cancer fight, Gene and cell, Medicine
| + My List |
| ALPN | | Alpine Immune Sciences, Inc. - Common Stock | | | -3.33% -3.33% 0 | | + Medicine, Cancer fight
| + My List |
| ALRN | | Aileron Therapeutics, Inc. - Common Stock | | | 0 | | + Cancer fight, Medicine, Biopharma
| + My List |
| ALXO | | ALX Oncology Holdings Inc. - Common Stock | | | down 7.67% -7.67 | | + Medicine, Cancer fight
| + My List |
| ANAB | | AnaptysBio, Inc. - Common Stock | | | down 8.71% -8.71 | | + Immunology, Cancer fight, Medicine
| + My List |
| ANCN | | Anchiano Therapeutics Ltd. - American Depositary Shares | | | 0.00% 0 | | + Cancer fight, Biopharma, Medicine, Country: Israel
| + My List |
| ANIX | | Anixa Biosciences, Inc. - Common Stock | | | down 10% -10 | | + Cancer fight, Medicine, Immunology
| + My List |
| ANPC | | AnPac Bio-Medical Science Co., Ltd. - American Depositary Shares | | | 0 | | + Cancer fight
Last highlighted: #ANPC SEC report: AnPac Bio-Medical Science Co., Ltd. [Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
SEC Filing Form 20-F/A filed by AnPac Bio-Medical Science Co., Ltd. -- SEC File Number 211081601 | + My List |
| APOP | | Cellect Biotechnology Ltd. - American Depositary Shares | | | 0.00% 0 | | + Country: Israel, Cancer fight, Medicine
| + My List |
| APRE | | Aprea Therapeutics, Inc. - Common Stock | | | up -8.41% 8.41 | | + Medicine, Cancer fight
Last highlighted: Aprea Therapeutics Inc trading halted, news pending
$APRE | + My List |
| ARAV | | Aravive, Inc. - Common Stock | | | up -7% 7 | | + Medicine, Cancer fight
| + My List |
| ATNX | | Athenex, Inc. - Common Stock | | | 0 | | + Cancer fight, Biopharma, Covid (fighting)
Last highlighted: $ATNX 📜 SEC Form 10-Q filed by Athenex, Inc.
https://t.co/1k3SCVGjG9
30 seconds delayed. | + My List |
| AUTL | | Autolus Therapeutics plc - American Depositary Shares | | | 10.77% 10.77% 0 | | + Country: Greate Britain, Gene and cell, Cancer fight, Medicine
Last highlighted: $AUTL Autolus Therapeutics to Report First Quarter 2021 Financial Results and Host Conference Call on May 6
https://t.co/Bswi1mwqgf | + My List |
| AVCO | | Avalon GloboCare Corp. - Common Stock | | | 0 | | + Cancer fight, Medicine, Immunology, Pharmaceutical
Last highlighted: #AVCO SEC report: Avalon GloboCare Corp. Current report, items 1.01 and 9.01
SEC Filing Form 8-K filed by Avalon GloboCare Corp. -- SEC File Number 211089336 | + My List |
| AVEO | | AVEO Pharmaceuticals, Inc. - Common Stock | | | down 9.82% -9.82 | | + Medicine, Disease: Oncology, Cancer fight
Last highlighted: #AVEO SEC report: AVEO PHARMACEUTICALS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by AVEO PHARMACEUTICALS, INC. -- SEC File Number 211148137 | + My List |
| AWH | | Aspira Women's Health Inc. - Common Stock | | | down 8% -8 | | + Cancer fight, Women Health, Medicine
| + My List |
| AYLA | | Ayala Pharmaceuticals, Inc. - Common Stock | | | up -12.66% 12.66 | | + Medicine, Cancer fight
| + My List |
| BLRX | | BioLineRx Ltd. - American Depositary Shares | | | down 10.29% -10.29 | | + Medicine, Cancer fight
| + My List |
| BNGO | | Bionano Genomics, Inc. - Common Stock | | | down 10.42% -10.42 | | + Medicine, Cancer fight, Gene and cell
Last highlighted: Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. to Accelerate Clinical Adoption of Saphyr for Digital Cytogenetics https://t.co/Q8ywclbV2i | + My List |
| BNGOW | | Bionano Genomics, Inc. - Warrant | | | 0 | | + Cancer fight, Medicine, Gene and cell
| + My List |
| BNR | | Burning Rock Biotech Limited - American Depositary Shares | | | down 7.58% -7.58 | | + Country: China, Cancer fight, Medicine
| + My List |
| BPTH | | Bio-Path Holdings, Inc. - Common Stock | | | -11.84% -11.84% 0 | | + Cancer fight, Medicine
| + My List |
| BYSI | | BeyondSpring, Inc. - Ordinary Shares | | | 8.16% 8.16% 0 | | + Cancer fight, Biopharma, Medicine, Immunology
Last highlighted: Form 6-K (report of foreign issuer [rules 13a-16 and 15d-16]) filed with the SEC $BYSI https://t.co/AH1YS5LVCR | + My List |
| CALA | | Calithera Biosciences, Inc. - Common Stock | | | down 17.5% -17.5 | | + Medicine, Cancer fight
| + My List |
| CBLI | | Cleveland BioLabs, Inc. - Common Stock | | | 0.00% 0 | | + Cancer fight
| + My List |
| CCXI | | ChemoCentryx, Inc. - Common Stock | | | 9.06% 9.06% 0 | | + Biopharma, Cancer fight, Immunology, Medicine
Last highlighted: #CCXI SEC report: ChemoCentryx, Inc. Current report, items 7.01, 8.01, and 9.01 | + My List |
| CELC | | Celcuity Inc. - Common Stock | | | down 9.09% -9.09 | | + Cancer fight, Medicine
Last highlighted: #CELC SEC report: Celcuity Inc. Statement of acquisition of beneficial ownership by individuals
SEC Filing Form SC 13G filed by Celcuity Inc. -- SEC File Number 211081754 | + My List |
| CGIX | | Cancer Genetics, Inc. - Common Stock | | | 0.00% 0 | | + Cancer fight, Medicine
| + My List |
| CKPT | | Checkpoint Therapeutics, Inc. - Common Stock | | | down 12.31% -12.31 | | + Cancer fight, Medicine
| + My List |
| CLDX | | Celldex Therapeutics, Inc. - Common Stock | | | 6.87% down 7.37% -0.5 | | + Cancer fight, Immunology, Medicine
Last highlighted: #CLDX SEC report: Celldex Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Celldex Therapeutics, Inc. -- SEC File Number 211148052 | + My List |
| CLLS | | Cellectis S.A. - American Depositary Shares | | | down 7.51% -7.51 | | + Biopharma, Medicine, Cancer fight
| + My List |
| CLRB | | Cellectar Biosciences, Inc. - Common Stock | | | down 13.16% -13.16 | | + Medicine, Biopharma, Cancer fight
Last highlighted: #CLRB SEC report: Cellectar Biosciences, Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Cellectar Biosciences, Inc. -- SEC File Number 211087932 | + My List |
| CLSN | | Celsion Corporation - Common Stock | | | down 8.87% -8.87 | | + Cancer fight, Medicine
| + My List |
| CMPI | | Checkmate Pharmaceuticals, Inc. - Common Stock | | | 327.57% up 326.75% 0.81999999999999 | | + Cancer fight, Medicine, Pharmaceutical
Last highlighted: #CMPI SEC report: Checkmate Pharmaceuticals, Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Checkmate Pharmaceuticals, Inc. -- SEC File Number 211142205 | + My List |
| CNST | | Constellation Pharmaceuticals, Inc. - Common Stock | | | 0.00% 0 | | + Cancer fight, Medicine, Pharmaceutical
| + My List |
| CRDF | | Cardiff Oncology, Inc. - Common Stock | | | down 9.35% -9.35 | | + Cancer fight, Medicine
Last highlighted: #CRDF SEC report: Cardiff Oncology, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Cardiff Oncology, Inc. -- SEC File Number 211148042 | + My List |
| CRIS | | Curis, Inc. - Common Stock | | | -5.61% down -5.61 | | + Cancer fight, Medicine
| + My List |
| CSTL | | Castle Biosciences, Inc. - Common stock | | | -6.67% up -7.15% 0.48 | | + Cancer fight, Medicine
| + My List |
| CTMX | | CytomX Therapeutics, Inc. - Common Stock | | | -5.42% -5.42% 0 | | + Biopharma, Cancer fight, Disease: Oncology
- Bad infrastructure
| + My List |
| CUE | | Cue Biopharma, Inc. - Common Stock | | | -1.29% -1.29% 0 | | + Biopharma, Immunology, Cancer fight
| + My List |
| CYCCP | | Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | | | up -10.17% 10.17 | | + Cancer fight, Medicine, Biopharma
Last highlighted: Filing Alert, FORM 8-K [Press/News Current Report] available. $CYCC $CYCCP #CyclacelPharmaceuticals, Inc. https://t.co/wcEcOgiN2c | + My List |
| DCTH | | Delcath Systems, Inc. - Common Stock | | | 6.19% down 13.61% -7.42 | | + Cancer fight, Medicine, Disease: Liver
Last highlighted: #DCTH SEC report: DELCATH SYSTEMS, INC. Notice of Effectiveness | + My List |
| DMTK | | DermTech, Inc. - Common Stock | | | -22.87% -22.87% 0 | | + Medicine, Cancer fight, Skin
Last highlighted: #DMTK SEC report: DermTech, Inc. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by DermTech, Inc. -- SEC File Number | + My List |
| DTIL | | Precision BioSciences, Inc. - Common Stock | | | -7.47% -7.47% 0 | | + Cancer fight, Gene and cell, Food
| + My List |
| ENOB | | Enochian Biosciences, Inc. - Common Stock | | | down 7.14% -7.14 | | + Disease: Infectious, Cancer fight, Immunology, Medicine
| + My List |
| EPIX | | ESSA Pharma Inc. - Common Stock | | | -7.85% -7.85% 0 | | + Pharmaceutical , Country: Canada, Cancer fight
Last highlighted: #EPIX SEC report: ESSA Pharma Inc. [Amend] Statement of acquisition of beneficial ownership by individuals
SEC Filing Form SC 13G/A filed by ESSA Pharma Inc. -- SEC File Number 211182253 | + My List |
| EPZM | | Epizyme, Inc. - Common Stock | | | -3.29% -3.29% 0 | | + Cancer fight, Gene and cell
| + My List |
| FATE | | Fate Therapeutics, Inc. - Common Stock | | | 7.34% 7.34% 0 | | + Cancer fight, Immunology, Medicine
| + My List |
| FGEN | | FibroGen, Inc - Common Stock | | | down 8.27% -8.27 | | + Medicine, Cancer fight, Respiratory therapies / Pulmanory
| + My List |
| FLDM | | Fluidigm Corporation - Common Stock | | | -7.02% -7.02% 0 | | + Life Sciences, Biology, Cancer fight, Biotechnology, RNA
Last highlighted: #FLDM SEC report: FLUIDIGM CORP Current report, items 1.01, 2.03, and 9.01
SEC Filing Form 8-K filed by FLUIDIGM CORP -- SEC File Number 211148270 | + My List |
| FPRX | | Five Prime Therapeutics, Inc. - Common Stock | | | 0.00% 0 | | + Cancer fight, Medicine
| + My List |
| FUSN | | Fusion Pharmaceuticals Inc. - Common Shares | | | -7.98% -7.98% 0 | | + Pharmaceutical , Country: Canada, Medicine, Radiotherapy, Cancer fight
| + My List |
| GALT | | Galectin Therapeutics Inc. - Common Stock | | | up -8.09% 8.09 | | + Cancer fight, Disease: Liver, Skin, Medicine
Last highlighted: #GALT SEC report: GALECTIN THERAPEUTICS INC Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by GALECTIN THERAPEUTICS INC -- SEC File Number 211081679 | + My List |
| GLSI | | Greenwich LifeSciences, Inc. - Common stock | | | -9.76% down -8.86% -0.9 | | + Medicine, Biopharma, Cancer fight, Immunology
| + My List |
| GNCA | | Genocea Biosciences, Inc. - Common Stock | | | 0 | | + Cancer fight, Immunology, Medicine
| + My List |
| GNPX | | Genprex, Inc. - Common Stock | | | -1.5% down 8.46% -9.96 | | + Cancer fight, Disease: Oncology, Medicine
Last highlighted: $GNPX [15s. delayed] filed form 10-Q on August 13, 16:34:15 https://t.co/cEVufMKwcd | + My List |
| GOVX | | GeoVax Labs, Inc. - Common Stock | | | -14.68% -14.68% 0 | | + Medicine, Cancer fight
| + My List |
| GRTS | | Gritstone Oncology, Inc. - Common Stock | | | down 18.13% -18.13 | | + Medicine, Immunology, Cancer fight
| + My List |
| GTH | | Genetron Holdings Limited - American Depositary Shares | | | up -9.52% 9.52 | | + Cancer fight, Medicine, Disease: Oncology, Country: China
Last highlighted: $GTH / Genetron Holdings Limited ADS files form 6-K https://t.co/3DehdripqL | + My List |
| HCM | | Hutchison China MediTech Limited - American Depositary Shares | | | -2.59% -2.59% 0 | | + Country: China, Medicine, Disease: Oncology, Cancer fight
Last highlighted: $HCM 📜 SEC Form 6-K filed by Hutchison China MediTech Limited
https://t.co/3MQ4DYnXFz
15s delayed. | + My List |
| HGEN | | Humanigen, Inc. - Common Stock | | | up -101.22% 101.22 | | + Biopharma, Immunology, Cancer fight, Medicine
Last highlighted: #HGEN SEC report: HUMANIGEN, INC Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by HUMANIGEN, INC -- SEC File Number 211142187 | + My List |
| HOOK | | HOOKIPA Pharma Inc. - Common Stock | | | up -7.09% 7.09 | | + Disease: Infectious, Immunology, Cancer fight, Medicine
| + My List |
| HTBX | | Heat Biologics, Inc. - Common Stock | | | 1.27% 1.27% 0 | | + Medicine, Cancer fight
| + My List |
| ICAD | | icad inc. - Common Stock | | | -4.19% down 12.59% -16.78 | | + Medicine, Devices, Cancer fight
Last highlighted: #ICAD SEC report: ICAD INC Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by ICAD INC -- SEC File Number | + My List |
| ILMN | | Illumina, Inc. - Common Stock | | | -6.04% up -20.6% 14.56 | | + Medicine, Gene and cell, Biology, Cancer fight, Reproductive health
Last highlighted: #ILMN SEC report: ILLUMINA, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by ILLUMINA, INC. -- SEC File Number 211148268 | + My List |
| IMMP | | Immutep Limited - American Depositary Shares | | | -0.48% up -9.18% 8.7 | | + Cancer fight, Medicine
| + My List |
| IMNM | | Immunome, Inc. - Common Stock | | | down 15.23% -15.23 | | + Cancer fight, Biotechnology, Medicine, Immunology
| + My List |
| IMTX | | Immatics N.V. - Ordinary Shares | | | down 7.59% -7.59 | | + Immunology, Cancer fight, Disease: Oncology, Medicine
| + My List |
| INFI | | Infinity Pharmaceuticals, Inc. - Common Stock | | | 0 | | + Medicine, Cancer fight
Last highlighted: #INFI SEC report: INFINITY PHARMACEUTICALS, INC. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by INFINITY PHARMACEUTICALS, INC. -- SEC File Number | + My List |
| INMB | | INmune Bio Inc. - Common stock | | | down 7.21% -7.21 | | + Immunology, Cancer fight, Disease: Oncology, Medicine
| + My List |
| IOVA | | Iovance Biotherapeutics, Inc. - Common Stock | | | down 8.94% -8.94 | | + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based
Last highlighted: #IOVA SEC report: IOVANCE BIOTHERAPEUTICS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by IOVANCE BIOTHERAPEUTICS, INC. -- SEC File Number 211148127 | + My List |
| ITOS | | iTeos Therapeutics, Inc. - Common Stock | | | -1.85% -1.85% 0 | | + Cancer fight, Biopharma, Disease: Oncology, Immunology, Medicine
Last highlighted: $ITOS 📜 iTeos Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement
https://t.co/fsH6i8bthL
15s delayed. | + My List |
| JNCE | | Jounce Therapeutics, Inc. - Common Stock | | | 8.81% 8.81% 0 | | + Immunology, Cancer fight, Medicine
| + My List |
| KPTI | | Karyopharm Therapeutics Inc. - Common Stock | | | 10.49% 10.49% 0 | | + Cancer fight, Disease: Oncology, Pharmaceutical , Medicine
Last highlighted: #KPTI SEC report: Karyopharm Therapeutics Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Karyopharm Therapeutics Inc. -- SEC File Number | + My List |
| KRBP | | Kiromic BioPharma, Inc. - Common Stock | | | 0 | | + Biopharma, Cancer fight, Immunology, Medicine
Last highlighted: #KRBP SEC report: Kiromic Biopharma, Inc. Statement of acquisition of beneficial ownership by individuals | + My List |
| KTRA | | Kintara Therapeutics, Inc. - Common Stock | | | 0 | | + Cancer fight, Medicine
| + My List |
| KURA | | Kura Oncology, Inc. - Common Stock | | | -0.67% up -7.8% 7.13 | | + Cancer fight, Medicine
Last highlighted: #KURA SEC report: Kura Oncology, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Kura Oncology, Inc. -- SEC File Number 211148278 | + My List |
| MACK | | Merrimack Pharmaceuticals, Inc. - Common Stock | | | -10.58% -10.58% 0 | | + Pharmaceutical , Cancer fight, Medicine
| + My List |
| MBRX | | Moleculin Biotech, Inc. - Common Stock | | | up -7.02% 7.02 | | + Biotechnology, Pharmaceutical , Medicine, Cancer fight, Disease: Infectious
Last highlighted: #MBRX SEC report: Moleculin Biotech, Inc. Statement of changes in beneficial ownership of securities | + My List |
| MGNX | | MacroGenics, Inc. - Common Stock | | | down 10.63% -10.63 | | + Medicine, Cancer fight
| + My List |
| MGTA | | Magenta Therapeutics, Inc. - Common Stock | | | down 9.09% -9.09 | | + Gene and cell, Cancer fight, Blood, Immunology, Medicine
Last highlighted: #MGTA SEC report: Magenta Therapeutics, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Magenta Therapeutics, Inc. -- SEC File Number 211084159 | + My List |
| MNPR | | Monopar Therapeutics Inc. - Common Stock | | | up -8.67% 8.67 | | + Cancer fight, Medicine, Biopharma
Last highlighted: #MNPR SEC report: Monopar Therapeutics Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Monopar Therapeutics -- SEC File Number 211138054 | + My List |
| MOR | | MorphoSys AG - American Depositary Shares | | | 2.12% down 9.5% -7.38 | | + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight
| + My List |
| MREO | | Mereo BioPharma Group plc - American Depositary Shares | | | -8.53% -8.53% 0 | | + Biopharma, Cancer fight, Country: Greate Britain
Last highlighted: #MREO SEC report: Mereo Biopharma Group plc Registration statement by foreign private issuers
SEC Filing Form F-3 filed by Mereo Biopharma Group plc -- SEC File Number 211148904 | + My List |
| MRKR | | Marker Therapeutics, Inc. - Common Stock | | | 0 | | + Immunology, Medicine, Cancer fight
Last highlighted: #MRKR SEC report: Marker Therapeutics, Inc. Current report, items 7.01 and 9.01 | + My List |
| MRSN | | Mersana Therapeutics, Inc. - Common Stock | | | 20.39% 20.39% 0 | | + Medicine, Cancer fight
Last highlighted: #MRSN SEC report: Mersana Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Mersana Therapeutics, Inc. -- SEC File Number | + My List |
| MRUS | | Merus N.V. - Common Shares | | | down 7.55% -7.55 | | + Cancer fight, Medicine, Country: Netherlands
Last highlighted: #MRUS SEC report: Merus N.V. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by Merus N.V. -- SEC File Number 211148220 | + My List |
| NCNA | | NuCana plc - American Depositary Shares | | | 6.91% down 7.43% -0.52 | | + Cancer fight, Disease: Oncology, Medicine
| + My List |
| NH | | NantHealth, Inc. - Common Stock | | | 0 | | + Cancer fight, Medicine
- Bad infrastructure
| + My List |
| NK | | NantKwest, Inc. - Common Stock | | | 0.00% 0 | | + Cancer fight, Medicine, Immunology
- Bad infrastructure
| + My List |
| NRIX | | Nurix Therapeutics, Inc. - Common stock | | | down 7.01% -7.01 | | + Biotechnology, Cancer fight, Immunology
Last highlighted: #NRIX SEC report: Nurix Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Nurix Therapeutics, Inc. -- SEC File Number 211088020 | + My List |
| NVCR | | NovoCure Limited - Ordinary Shares | | | 4.18% down 8.39% -4.21 | | + Cancer fight, Medicine
| + My List |
| ODT | | Odonate Therapeutics, Inc. - Common Stock | | | 0.00% 0 | | + Cancer fight, Medicine
Last highlighted: #ODT SEC report: Odonate Therapeutics, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Odonate Therapeutics, Inc. -- SEC File Number 211148890 | + My List |
| ONCR | | Oncorus, Inc. - Common Stock | | | 7.48% 7.48% 0 | | + Cancer fight, Immunology, Biotechnology
Last highlighted: #ONCR SEC report: Oncorus, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Oncorus, Inc. -- SEC File Number 211142316 | + My List |
| ONCS | | OncoSec Medical Incorporated - Common Stock | | | 0 | | + Cancer fight, Disease: Oncology, Medicine, Immunology
Last highlighted: #ONCS SEC report: ONCOSEC MEDICAL Inc Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by ONCOSEC MEDICAL Inc -- SEC File Number | + My List |
| ONCY | | Oncolytics Biotech Inc. - Common Shares | | | 2.44% 2.44% 0 | | + Medicine, Cancer fight, Country: Canada, Immunology
Last highlighted: $ONCY / Oncolytics Biotech files form 6-K https://t.co/G1byP6giz8 | + My List |
| ORIC | | Oric Pharmaceuticals, Inc. - Common Stock | | | down 18.36% -18.36 | | + Pharmaceutical , Medicine, Disease: Oncology, Cancer fight
Last highlighted: #ORIC SEC report: Oric Pharmaceuticals, Inc. Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by Oric Pharmaceuticals, Inc. -- SEC File Number 211078899 | + My List |
| PDSB | | PDS Biotechnology Corporation - Common Stock | | | down 10.87% -10.87 | | + Biotechnology, Immunology, Cancer fight, Disease: Oncology, Medicine
Last highlighted: RT @EdgarInsider: FORM 8-K [Press/News Current Report] recently SEC filed. $PDSB $EDGE PDS Biotechnology Corp https://t.co/FKxSQ3btJT | + My List |
| PHIO | | Phio Pharmaceuticals Corp. - Common Stock | | | 0 | | + Medicine, Cancer fight, Immunology
Last highlighted: #PHIO SEC report: Phio Pharmaceuticals Corp. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Phio Pharmaceuticals Corp. -- SEC File Number | + My List |
| PIRS | | Pieris Pharmaceuticals, Inc. - Common Stock | | | 1.18% down 7.05% -5.87 | | + Biopharma, Respiratory therapies / Pulmanory, Medicine, Immunology, Cancer fight
Last highlighted: #PIRS SEC report: PIERIS PHARMACEUTICALS, INC. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by PIERIS PHARMACEUTICALS, INC. -- SEC File Number 211142334 | + My List |
| PMVP | | PMV Pharmaceuticals, Inc. - Common Stock | | | down 11% -11 | | + Medicine, Cancer fight, Pharmaceutical
Last highlighted: #PMVP SEC report: PMV Pharmaceuticals, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by PMV Pharmaceuticals, Inc. -- SEC File Number | + My List |
| POAI | | Predictive Oncology Inc. - Common Stock | | | 0 | | + Cancer fight, Medicine, Artificial Intelligence
Last highlighted: #POAI SEC report: Predictive Oncology Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Predictive Oncology Inc. -- SEC File Number | + My List |
| PRLD | | Prelude Therapeutics Incorporated - Common Stock | | | down 7.59% -7.59 | | + Cancer fight, Medicine
Last highlighted: #PRLD SEC report: Prelude Therapeutics Inc Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Prelude Therapeutics Inc -- SEC File Number | + My List |
| PROG | | Progenity, Inc. - Common Stock | | | 0 | | + Gene and cell, Medicine, Cancer fight, Women Health
Last highlighted: #PROG SEC report: PROGENITY, INC. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by PROGENITY, INC. -- SEC File Number | + My List |
| PSTV | | PLUS THERAPEUTICS, Inc. - Common Stock | | | 0 | | + Cancer fight, Medicine, Radiotherapy
Last highlighted: #PSTV SEC report: PLUS THERAPEUTICS, INC. [Amend] Quarterly report [Sections 13 or 15(d)] | + My List |
| QTRX | | Quanterix Corporation - Common Stock | | | -27.53% down -26.86% -0.67 | | + Healthcare, Biology, Disease: Infectious, Disease: Cardiovascular, Cancer fight, Disease: Oncology
Last highlighted: #QTRX SEC report: Quanterix Corp Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Quanterix Corp -- SEC File Number | + My List |
| RAPT | | RAPT Therapeutics, Inc. - Common Stock | | | down 7.75% -7.75 | | + Cancer fight, Medicine
Last highlighted: #RAPT SEC report: RAPT Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by RAPT Therapeutics, Inc. -- SEC File Number | + My List |
| REPL | | Replimune Group, Inc. - Common Stock | | | -1.60% -1.60% 0 | | + Cancer fight
Last highlighted: #REPL SEC report: Replimune Group, Inc. [Amend] Statement of changes in beneficial ownership of securities
SEC Filing Form 4/A filed by Replimune Group, Inc. -- SEC File Number | + My List |
| RIGL | | Rigel Pharmaceuticals, Inc. - Common Stock | | | up -13.87% 13.87 | | + Medicine, Cancer fight
| + My List |
| RUBY | | Rubius Therapeutics, Inc. - Common Stock | | | 9% 9% 0 | | + Gene and cell, Cancer fight, Medicine
| + My List |
| RVMD | | Revolution Medicines, Inc. - Common Stock | | | down 14.13% -14.13 | | + Cancer fight, Medicine, Biotechnology
| + My List |
| SESN | | Sesen Bio, Inc. - Common Stock | | | 0 | | + Cancer fight, Medicine
Last highlighted: #SESN SEC report: Sesen Bio, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Sesen Bio, Inc. -- SEC File Number 211102791 | + My List |
| SLRX | | Salarius Pharmaceuticals, Inc. - Common Stock | | | 0 | | + Cancer fight, Biotechnology, Medicine, Pharmaceutical
Last highlighted: $SLRX 8-K Salarius Pharmaceuticals (8 Mar, 4:30pm)
📰 Salarius Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
https://t.co/AWdEx2wgvD
#SLRX #8K #SalariusPharmaceuticals #News | + My List |
| SLS | | SELLAS Life Sciences Group, Inc. - Common Stock | | | down 11.04% -11.04 | | + Cancer fight, Medicine
Last highlighted: SELLAS Announces Positive Follow-up Data from the Randomized Phase 2 VADIS Trial of Nelipepimut-S (NPS) in Women with Ductal Carcinoma In-Situ of the Breast
https://www.sellaslifesciences.com/investors/news/News-Details/2020/SELLAS-Announces-Positive-Follow-up-Data-from-the-Randomized-Phase-2-VADIS-Trial-of-Nelipepimut-S-NPS-in-Women-with-Ductal-Carcinoma-In-Situ-of-the-Breast/default.aspx | + My List |
| SNSS | | Sunesis Pharmaceuticals, Inc. - Common Stock | | | 0.00% 0 | | + Medicine, Biopharma, Cancer fight
| + My List |
| SONN | | Sonnet BioTherapeutics Holdings, Inc. - Common Stock | | | 0 | | + Cancer fight, Biology, Medicine
| + My List |
| SRNE | | Sorrento Therapeutics, Inc. - Common Stock | | | 6.97% down 7.38% -0.41 | | + Pain fight, Cancer fight, Medicine
| + My List |
| STRO | | Sutro Biopharma, Inc. - Common Stock | | | 6.72% 6.72% 0 | | + Cancer fight, Medicine
| + My List |
| SURF | | Surface Oncology, Inc. - Common Stock | | | up -8% 8 | | + Cancer fight, Immunology, Medicine
Last highlighted: #SURF SEC report: Surface Oncology, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Surface Oncology, Inc. -- SEC File Number 211078938 | + My List |
| SYRS | | Syros Pharmaceuticals, Inc. - common stock | | | up -8% 8 | | + Gene and cell, Medicine, Cancer fight
| + My List |
| TARA | | Protara Therapeutics, Inc. - Common Stock | | | 7.6% down 8.25% -0.65 | | + Cancer fight, Medicine
| + My List |
| TCON | | TRACON Pharmaceuticals, Inc. - Common Stock | | | 7.26% 7.26% 0 | | + Pharmaceutical , Cancer fight, Medicine, Biopharma, Disease: Oncology
| + My List |
| TCRR | | TCR2 Therapeutics Inc. - Common Stock | | | 0.91% 0.91% 0 | | + Cancer fight, Medicine
| + My List |
| THTX | | Theratechnologies Inc. - Common Shares | | | -1.68% down 12.15% -13.83 | | + Cancer fight, Biopharma, Medicine
| + My List |
| TRIL | | Trillium Therapeutics Inc. - Common Shares | | | 0.00% 0 | | + Country: Canada, Cancer fight, Disease: Oncology, Immunology
Last highlighted: #TRIL SEC report: Trillium Therapeutics Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Trillium Therapeutics Inc. -- SEC File Number | + My List |
| TTOO | | T2 Biosystems, Inc. - Common Stock | | | 0 | | + Medicine, Cancer fight
Last highlighted: #TTOO SEC report: T2 Biosystems, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by T2 Biosystems, Inc. -- SEC File Number | + My List |
| TYME | | Tyme Technologies, Inc. - Common Stock | | | 0 | | + Cancer fight, Medicine
Last highlighted: #TYME SEC report: TYME TECHNOLOGIES, INC. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by TYME TECHNOLOGIES, INC. -- SEC File Number | + My List |
| VBLT | | Vascular Biogenics Ltd. - Ordinary Shares | | | -77.94% -77.94% 0 | | + Country: Israel, Biopharma, Cancer fight, Medicine
| + My List |
| VERU | | Veru Inc. - Common Stock | | | up -9.91% 9.91 | | + Cancer fight, Medicine
Last highlighted: Veru, Inc. (VERU) CEO Mitchell Steiner on Q4 2020 Results - Earnings Call Transcript | + My List |
| VRAY | | ViewRay, Inc. - Common Stock | | | down 9.5% -9.5 | | + Cancer fight, Radiotherapy, Medicine
Last highlighted: #VRAY SEC report: ViewRay, Inc. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by ViewRay, Inc. -- SEC File Number 211148242 | + My List |
| VSTM | | Verastem, Inc. - Common Stock | | | 9.4% 9.4% 0 | | + Biopharma, Cancer fight, Medicine
Last highlighted: #VSTM SEC report: Verastem, Inc. Automatic shelf registration statement of securities of well-known seasoned issuers
SEC Filing Form S-3ASR filed by Verastem, Inc. -- SEC File Number 211136620 | + My List |
| XBIO | | Xenetic Biosciences, Inc. - Common Stock | | | 0 | | + Biopharma, Cancer fight, Disease: Oncology, Medicine
| + My List |
| XFOR | | X4 Pharmaceuticals, Inc. - Common Stock | | | up -10% 10 | | + Cancer fight, Medicine, Pharmaceutical
Last highlighted: #XFOR SEC report: X4 Pharmaceuticals, Inc Current report, item 2.02
SEC Filing Form 8-K filed by X4 Pharmaceuticals, Inc -- SEC File Number 211138073 | + My List |
| YMAB | | Y-mAbs Therapeutics, Inc. - Common Stock | | | 7.5% 7.5% 0 | | + Biopharma, Cancer fight, Medicine
Last highlighted: #YMAB SEC report: Y-mAbs Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Y-mAbs Therapeutics, Inc. -- SEC File Number 211148421 | + My List |
| ZIOP | | ZIOPHARM Oncology Inc - Common Stock | | | 0 | | + T cell-based, Cancer fight, Disease: Oncology, Immunology, Medicine
| + My List |
| ZNTL | | Zentalis Pharmaceuticals, Inc. - common stock | | | -12.34% down -11.02% -1.32 | | + Cancer fight, Biology, Pharmaceutical , Medicine
Last highlighted: #ZNTL SEC report: Zentalis Pharmaceuticals, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Zentalis Pharmaceuticals, Inc. -- SEC File Number | + My List |
| BCTX | | BriaCell Therapeutics Corp. - Common Shares | | | 3.83% down 8.82% -4.99 | | + Cancer fight, Immunology, Medicine, Disease: Oncology
Last highlighted: #BCTX SEC report: BriaCell Therapeutics Corp. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by BriaCell Therapeutics Corp. -- SEC File Number 211182540 | + My List |
| BOLT | | Bolt Biotherapeutics, Inc. - Common Stock | | | up -7.11% 7.11 | | + Immunology, Cancer fight, Disease: Oncology, Medicine
| + My List |
| ENVB | | Enveric Biosciences, Inc. - Common Stock | | | -10.65% -10.65% 0 | | + Biotechnology, Cancer fight, Medicine, Cannabis, Disease: Oncology
Last highlighted: #ENVB SEC report: Enveric Biosciences, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Enveric Biosciences, Inc. -- SEC File Number 211084155 | + My List |
| EVAX | | Evaxion Biotech A/S - American Depositary Share | | | 14.29% 14.29% 0 | | + Cancer fight, Disease: Oncology, Immunology, Medicine, Biotechnology, Biology
Last highlighted: #EVAX SEC report: Evaxion Biotech A/S Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Evaxion Biotech A/S -- SEC File Number 211078935 | + My List |
| FSTX | | F-star Therapeutics, Inc. - Common Stock | | | 11.8% 11.8% 0 | | + Immunology, Medicine, Cancer fight, Disease: Oncology
Last highlighted: #FSTX SEC report: F-star Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by F-star Therapeutics, Inc. -- SEC File Number | + My List |
| GTBP | | GT Biopharma, Inc. - Common Stock | | | 10.14% down 11.28% -1.14 | | + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight
Last highlighted: #GTBP SEC report: GT Biopharma, Inc. Notification of inability to timely file Form 10-Q or 10-QSB
SEC Filing Form NT 10-Q filed by GT Biopharma, Inc. -- SEC File Number 211181131 | + My List |
| LIXT | | Lixte Biotechnology Holdings, Inc. - Common Stock | | | 0 | | + Biotechnology, Cancer fight, Disease: Oncology, Medicine
Last highlighted: #LIXT SEC report: LIXTE BIOTECHNOLOGY HOLDINGS, INC. Current report, item 5.07
SEC Filing Form 8-K filed by LIXTE BIOTECHNOLOGY HOLDINGS, INC. -- SEC File Number 211083663 | + My List |
| OCX | | OncoCyte Corporation - Common Stock | | | -9.9% -9.9% 0 | | + Cancer fight, Diagnosing, Medicine
Last highlighted: #OCX SEC report: OncoCyte Corp Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by OncoCyte Corp -- SEC File Number 211160996 | + My List |
| PPBT | | Purple Biotech Ltd. - American Depositary Shares | | | -7.94% up -8.73% 0.79 | | + Country: Israel, Cancer fight, Disease: Oncology
| + My List |
| PRTG | | Portage Biotech Inc. - Common Stock | | | -7.7% -7.7% 0 | | + Country: Canada, Immunology, Cancer fight, Disease: Oncology
| + My List |
| SBTX | | Silverback Therapeutics, Inc. - Common Stock | | | 7.1% 7.1% 0 | | + Cancer fight, Disease: Oncology, Disease: Infectious, Medicine
| + My List |
| SCPS | | Scopus BioPharma Inc. - Common Stock | | | 0 | | + Immunology, Cancer fight, Medicine, Disease: Oncology, Biopharma
Last highlighted: Alert [Quarterly Report] / Form 10-Q filed with the SEC $SCPS Scopus BioPharma Inc. Scopus BioPharma Inc https://t.co/lmBK4v1IJB | + My List |
| VOR | | Vor Biopharma Inc. - Common Stock | | | 7.03% 7.03% 0 | | + Biopharma, Medicine, Cancer fight, Disease: Oncology
| + My List |
| IKNA | | Ikena Oncology, Inc. - Common Stock | | | 8.17% 8.17% 0 | | + Cancer fight, Disease: Oncology, Medicine
| + My List |
| LVTX | | LAVA Therapeutics N.V. - Ordinary Shares | | | 7.06% down 7.82% -0.76 | | + T cell-based, Cancer fight, Medicine, Disease: Oncology
| + My List |